<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01869699</url>
  </required_header>
  <id_info>
    <org_study_id>UCSF-ICUFever</org_study_id>
    <nct_id>NCT01869699</nct_id>
  </id_info>
  <brief_title>Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults</brief_title>
  <acronym>ICUFeverAPAP</acronym>
  <official_title>Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects of intravenous acetaminophen to placebo
      on body temperature and hemodynamic (heart rate and blood pressure) responses in febrile
      critically ill adult patients.

      There are limited data to explain the variable and unpredictable antipyretic and hemodynamic
      response to acetaminophen in febrile ICU patients. The complex pathophysiology of critically
      ill patients, co-morbid conditions, the effect of multiple pharmacologic and
      non-pharmacologic care interventions, and/or the potential interferences with absorption of
      enteral or rectal formulations may be related to variations in the antipyretic response to
      acetaminophen. It is necessary for clinicians to have a better understanding of the therapy
      response and potential adverse effects of this commonly administered medication, especially
      the recently available IV formulation, in critically ill patients. Further research of the
      antipyretic response to acetaminophen in critically ill patients is warranted to inform
      evidence-based practice guidelines for fever management. Further randomized,
      placebo-controlled studies of hemodynamic responses to IV acetaminophen are also warranted.

      Primary Hypothesis:

      There is a significant reduction in time-weighted average core body temperature over 4 hours
      after administration of IV acetaminophen compared to placebo in febrile critically ill
      patients.

      Secondary Hypotheses:

        1. There is a significant reduction in time-weighted average heart rate over 4 hours after
           administration of IV acetaminophen compared to placebo in febrile critically ill
           patients.

        2. There is a significant reduction in time-weighted mean arterial pressure over 4 hours
           after administration of IV acetaminophen compared to placebo in febrile critically ill
           patients.

      Adult patients with fever (≥ 38.3ºCentigrade/101ºFarenheit) in the intensive care unit will
      be screened for eligibility and enrolled after informed consent. Patients will be randomized
      to receive IV acetaminophen 1 gram or normal saline 100 mLs. Body temperature, heart rate,
      and blood pressure will be measured at baseline and during the 4 hours post study drug
      administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients with fever (≥ 38.3ºCentigrade (C)/101ºFarenheit(F)) in the intensive care unit
      will be screened for eligibility and approached for informed consent. Enrolled patients will
      be stratified based on the leading etiology of their fever: either neurologic injury or
      infection and then randomized to receive IV acetaminophen 1 gram or normal saline 100
      milliliters (mLs). Core body temperature will be measured using a zero-heat flow thermometry
      system (non-invasive, small disk on forehead). Patients will be monitored and data collected
      during the 4-hour post study drug administration period. A rescue protocol will be
      implemented if the temperature reaches ≥ 40 ºC during the study period and includes
      notification of primary team provider by the nurse and the pharmacist will contact them to
      inform the provider of study group (acetaminophen or placebo). The provider can decide
      whether to order antipyretic medication or physical cooling interventions at that time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Core Body Temperature</measure>
    <time_frame>Baseline to 4 hours post study drug administration</time_frame>
    <description>time-weighted average core body temperature over 4 hours. Core temperature was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the core temperature values was divided by time in minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline to 4 hours post study drug administration</time_frame>
    <description>time-weighted average heart rate over 4 hours. Heart rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the heart rate values was divided by time in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Baseline to 4 hours post study drug administration</time_frame>
    <description>time-weighted average systolic blood pressure over 4 hours. Systolic blood pressure was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the systolic blood pressure values was divided by time in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Baseline to 4 hours post study drug administration</time_frame>
    <description>time weighted average for respiratory rate over 4 hours. Respiratory rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the respiratory rate values was divided by time in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-hour Change Over Time Core Temperature</measure>
    <time_frame>2 hours</time_frame>
    <description>change over time core temperature after study drug administration (adjusted to baseline core temperature)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-hour Change Over Time Systolic Blood Pressure</measure>
    <time_frame>Baseline to 2 hours</time_frame>
    <description>2-hour change over time SBP from study drug administration (means adjusted to baseline SBP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-hour Change Over Time Heart Rate</measure>
    <time_frame>Baseline to 2 hours</time_frame>
    <description>2-hour change over time heart rate from time of study drug administration (means adjusted to baseline HR)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Fever</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Normal saline placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline 100 mLs intravenous, administered over 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
    <arm_group_label>Normal saline placebo</arm_group_label>
    <other_name>NS</other_name>
    <other_name>0.9% sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Patient in an intensive care unit

          -  Weight greater or equal to 50 kgs

          -  Fever: core body temperature greater than or equal to 38.3 degrees Celsius

          -  Clinically stable: no active resuscitation with fluids, blood products, or dose
             increases of vasoactive medications within 1 hour of study drug administration

        Exclusion Criteria:

          -  Acetaminophen hypersensitivity

          -  Acute liver failure or acute liver injury

          -  Heat stroke, malignant hyperthermia, neuroleptic malignant syndrome

          -  Therapeutic cooling, physical cooling, extracorporeal blood circuit therapies

          -  Administration of acetaminophen-containing medications, non-steroidal
             anti-inflammatory drugs, or aspirin greater than 81 mg within specified times per drug
             prior to fever presentation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathleen A. Puntillo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med. 2012 Jan;40(1):145-51. doi: 10.1097/CCM.0b013e31822f061d.</citation>
    <PMID>21926588</PMID>
  </reference>
  <reference>
    <citation>Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211. Erratum in: Crit Care. 2012;16(1):450.</citation>
    <PMID>22373120</PMID>
  </reference>
  <reference>
    <citation>Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, Stelfox HT. Occurrence and outcome of fever in critically ill adults. Crit Care Med. 2008 May;36(5):1531-5. doi: 10.1097/CCM.0b013e318170efd3.</citation>
    <PMID>18434882</PMID>
  </reference>
  <reference>
    <citation>Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med. 1999 Jul;25(7):668-73.</citation>
    <PMID>10470569</PMID>
  </reference>
  <reference>
    <citation>Frankenfield DC, Smith JS Jr, Cooney RN, Blosser SA, Sarson GY. Relative association of fever and injury with hypermetabolism in critically ill patients. Injury. 1997 Nov-Dec;28(9-10):617-21.</citation>
    <PMID>9624339</PMID>
  </reference>
  <reference>
    <citation>Thompson HJ, Kagan SH. Clinical management of fever by nurses: doing what works. J Adv Nurs. 2011 Feb;67(2):359-70. doi: 10.1111/j.1365-2648.2010.05506.x. Epub 2010 Nov 2.</citation>
    <PMID>21044137</PMID>
  </reference>
  <reference>
    <citation>Niven DJ, Stelfox HT, Laupland KB. Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis. J Crit Care. 2013 Jun;28(3):303-10. doi: 10.1016/j.jcrc.2012.09.009. Epub 2012 Nov 14. Review.</citation>
    <PMID>23159136</PMID>
  </reference>
  <reference>
    <citation>de Maat MM, Tijssen TA, Brüggemann RJ, Ponssen HH. Paracetamol for intravenous use in medium--and intensive care patients: pharmacokinetics and tolerance. Eur J Clin Pharmacol. 2010 Jul;66(7):713-9. doi: 10.1007/s00228-010-0806-5. Epub 2010 Mar 19.</citation>
    <PMID>20300741</PMID>
  </reference>
  <reference>
    <citation>Kett DH, Breitmeyer JB, Ang R, Royal MA. A randomized study of the efficacy and safety of intravenous acetaminophen vs. intravenous placebo for the treatment of fever. Clin Pharmacol Ther. 2011 Jul;90(1):32-9. doi: 10.1038/clpt.2011.98. Epub 2011 May 4.</citation>
    <PMID>21544074</PMID>
  </reference>
  <reference>
    <citation>Mackenzie I, Forrest K, Thompson F, Marsh R. Effects of acetaminophen administration to patients in intensive care. Intensive Care Med. 2000 Sep;26(9):1408.</citation>
    <PMID>11089781</PMID>
  </reference>
  <reference>
    <citation>Boyle M, Hundy S, Torda TA. Paracetamol administration is associated with hypotension in the critically ill. Aust Crit Care. 1997 Dec;10(4):120-2.</citation>
    <PMID>9708071</PMID>
  </reference>
  <reference>
    <citation>Boyle M, Nicholson L, O'Brien M, Flynn GM, Collins DW, Walsh WR, Bihari D. Paracetamol induced skin blood flow and blood pressure changes in febrile intensive care patients: An observational study. Aust Crit Care. 2010 Nov;23(4):208-14. doi: 10.1016/j.aucc.2010.06.004. Epub 2010 Jul 22.</citation>
    <PMID>20655241</PMID>
  </reference>
  <reference>
    <citation>Hersch M, Raveh D, Izbicki G. Effect of intravenous propacetamol on blood pressure in febrile critically ill patients. Pharmacotherapy. 2008 Oct;28(10):1205-10. doi: 10.1592/phco.28.10.1205.</citation>
    <PMID>18823215</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2013</study_first_submitted>
  <study_first_submitted_qc>June 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2013</study_first_posted>
  <results_first_submitted>June 9, 2017</results_first_submitted>
  <results_first_submitted_qc>July 11, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 9, 2017</results_first_posted>
  <last_update_submitted>July 11, 2017</last_update_submitted>
  <last_update_submitted_qc>July 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fever</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Critical Care</keyword>
  <keyword>ICU</keyword>
  <keyword>Febrile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normal Saline Placebo</title>
          <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
        </group>
        <group group_id="P2">
          <title>Acetaminophen</title>
          <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal Saline Placebo</title>
          <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
        </group>
        <group group_id="B2">
          <title>Acetaminophen</title>
          <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57" spread="13"/>
                    <measurement group_id="B2" value="58" spread="15"/>
                    <measurement group_id="B3" value="57.5" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>Body Mass Index (BMI) units of measure are kilograms per meter squared</description>
          <units>kilograms per meter squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" spread="7"/>
                    <measurement group_id="B2" value="29" spread="5"/>
                    <measurement group_id="B3" value="30" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary ICU diagnosis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Number of patients with Medical diagnoses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of patients with Surgical diagnoses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of patients iwth Neurologic diagnoses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute Physiologic and Chronic Health Evaluation (APACHE) II score</title>
          <description>Acute Physiologic and Chronic Health Evaluation (APACHE) II is a severity-of-disease classification system (Knaus et al., 1985), one of several ICU scoring systems. It is applied within 24 hours of admission of a patient to an intensive care unit (ICU): an integer score from 0 to 71 is computed based on several measurements; higher scores correspond to more severe disease.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="6"/>
                    <measurement group_id="B2" value="24" spread="6"/>
                    <measurement group_id="B3" value="24" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of patients with infectious and noninfectious etiology of fever</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Number of patients with Infectious etiology</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of patients with Noninfectious etiology</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of patients receiving types of medication infusions</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Number of patients on vasopressor infusions</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients on vasodilator infusions</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients on sedative infusions</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients on analgesic infusions</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients on no medication infusions</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of patients with sepsis</title>
          <description>Sepsis was defined as new confirmed or suspected infection and 2 or more systemic inflammatory response syndrome (SIRS) criteria. (Dellinger RP, Levy MM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013; 39: 165-228.)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of patients receiving Mechanical Ventilation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mode of ventilation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Number of patients on Pressure Support</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients on Assist Control</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of patients NOT on mechanical ventilation</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Temperature of room</title>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.5" spread="1.4"/>
                    <measurement group_id="B2" value="21.4" spread="1.2"/>
                    <measurement group_id="B3" value="21.4" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Core body temperature</title>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.6" spread="0.5"/>
                    <measurement group_id="B2" value="38.4" spread="0.3"/>
                    <measurement group_id="B3" value="38.5" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Rate</title>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93" spread="15"/>
                    <measurement group_id="B2" value="90" spread="14"/>
                    <measurement group_id="B3" value="91.5" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>systolic blood pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135" spread="26"/>
                    <measurement group_id="B2" value="151" spread="26"/>
                    <measurement group_id="B3" value="143" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>diastolic blood pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="13"/>
                    <measurement group_id="B2" value="73" spread="15"/>
                    <measurement group_id="B3" value="67.5" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>mean arterial pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89" spread="16"/>
                    <measurement group_id="B2" value="100" spread="20"/>
                    <measurement group_id="B3" value="94.5" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>respiratory rate</title>
          <units>breaths per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="5"/>
                    <measurement group_id="B2" value="20" spread="6"/>
                    <measurement group_id="B3" value="22" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Core Body Temperature</title>
        <description>time-weighted average core body temperature over 4 hours. Core temperature was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the core temperature values was divided by time in minutes.</description>
        <time_frame>Baseline to 4 hours post study drug administration</time_frame>
        <population>Patients in an ICU with fever, weighed &gt; 50kg and did not meet any exclusion criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Core Body Temperature</title>
          <description>time-weighted average core body temperature over 4 hours. Core temperature was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the core temperature values was divided by time in minutes.</description>
          <population>Patients in an ICU with fever, weighed &gt; 50kg and did not meet any exclusion criteria.</population>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4" spread="0.1"/>
                    <measurement group_id="O2" value="37.9" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We estimated that 20 patients per group would provide 80% power for detecting a difference in means of 0.6 degrees Celsius, with a pooled SD of 0.67 degrees, using a two group t test and a two sided alpha level of 0.05. A previous RCT of IV acetaminophen in healthy male volunteers with induced fever found a core temperature difference of 0.60 degrees with a common SD of 0.67 degrees Celsius.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.47</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.76</ci_lower_limit>
            <ci_upper_limit>-0.18</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>time-weighted average heart rate over 4 hours. Heart rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the heart rate values was divided by time in minutes.</description>
        <time_frame>Baseline to 4 hours post study drug administration</time_frame>
        <population>Patients in the ICU with fever, weight of &gt; 50kg and no exclusion criteria met.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>time-weighted average heart rate over 4 hours. Heart rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the heart rate values was divided by time in minutes.</description>
          <population>Patients in the ICU with fever, weight of &gt; 50kg and no exclusion criteria met.</population>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" spread="2"/>
                    <measurement group_id="O2" value="87" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10</ci_lower_limit>
            <ci_upper_limit>-1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure</title>
        <description>time-weighted average systolic blood pressure over 4 hours. Systolic blood pressure was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the systolic blood pressure values was divided by time in minutes.</description>
        <time_frame>Baseline to 4 hours post study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>time-weighted average systolic blood pressure over 4 hours. Systolic blood pressure was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the systolic blood pressure values was divided by time in minutes.</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="143" spread="3"/>
                    <measurement group_id="O2" value="127" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-25</ci_lower_limit>
            <ci_upper_limit>-8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate</title>
        <description>time weighted average for respiratory rate over 4 hours. Respiratory rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the respiratory rate values was divided by time in minutes.</description>
        <time_frame>Baseline to 4 hours post study drug administration</time_frame>
        <population>Patients in the ICU with fever, weight of &gt; 50kg and no exclusion criteria met.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate</title>
          <description>time weighted average for respiratory rate over 4 hours. Respiratory rate was measured every 5 minutes times 4, and then every 15 minutes over the following 4 hours from the time of study drug administration. The sum of the respiratory rate values was divided by time in minutes.</description>
          <population>Patients in the ICU with fever, weight of &gt; 50kg and no exclusion criteria met.</population>
          <units>breaths per minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22" spread="1"/>
                    <measurement group_id="O2" value="21" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.42</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4</ci_lower_limit>
            <ci_upper_limit>12</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-hour Change Over Time Core Temperature</title>
        <description>change over time core temperature after study drug administration (adjusted to baseline core temperature)</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>2-hour Change Over Time Core Temperature</title>
          <description>change over time core temperature after study drug administration (adjusted to baseline core temperature)</description>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="1.3"/>
                    <measurement group_id="O2" value="-0.8" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1</ci_lower_limit>
            <ci_upper_limit>-0.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-hour Change Over Time Systolic Blood Pressure</title>
        <description>2-hour change over time SBP from study drug administration (means adjusted to baseline SBP)</description>
        <time_frame>Baseline to 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>2-hour Change Over Time Systolic Blood Pressure</title>
          <description>2-hour change over time SBP from study drug administration (means adjusted to baseline SBP)</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="5"/>
                    <measurement group_id="O2" value="-24" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-24</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-38</ci_lower_limit>
            <ci_upper_limit>-10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>2-hour Change Over Time Heart Rate</title>
        <description>2-hour change over time heart rate from time of study drug administration (means adjusted to baseline HR)</description>
        <time_frame>Baseline to 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline Placebo</title>
            <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen</title>
            <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>2-hour Change Over Time Heart Rate</title>
          <description>2-hour change over time heart rate from time of study drug administration (means adjusted to baseline HR)</description>
          <units>BPM</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="2"/>
                    <measurement group_id="O2" value="-6" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-15</ci_lower_limit>
            <ci_upper_limit>-1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal Saline Placebo</title>
          <description>Normal saline 100 mLs intravenous, administered over 15 minutes
Placebo: Normal saline placebo Normal saline 100 mLs intravenous, administered over 15 minutes</description>
        </group>
        <group group_id="E2">
          <title>Acetaminophen</title>
          <description>Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes
Acetaminophen: acetaminophen 1 gram/100mLs intravenously administered over 15 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The generalizability of our findings is limited due to the use of a single site and our sample size was modest. Also, patients in this study had baseline stable and normal or high BP, so unclear if same results in patients with unstable or low BP.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Hildy Schell-Chaple</name_or_title>
      <organization>University of California, San Francisco</organization>
      <phone>415-353-1039</phone>
      <email>hildegarde.schell-chaple@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

